nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Fatigue—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Pain—Sunitinib—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Vancomycin—Constipation—Sunitinib—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Vancomycin—Phlebitis—Doxorubicin—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Vancomycin—Asthenia—Tamoxifen—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Vancomycin—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Vancomycin—Agranulocytosis—Docetaxel—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Asthenia—Erlotinib—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Pruritus—Tamoxifen—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Renal impairment—Epirubicin—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Vancomycin—Infection—Irinotecan—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Pruritus—Erlotinib—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Nervous system disorder—Irinotecan—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Vancomycin—Infection—Gemcitabine—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Abdominal pain—Sunitinib—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Body temperature increased—Sunitinib—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Oedema peripheral—Docetaxel—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Infection—Fluorouracil—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Skin disorder—Gemcitabine—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Dizziness—Tamoxifen—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Tachycardia—Fluorouracil—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Hypotension—Irinotecan—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Dizziness—Erlotinib—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Erythema multiforme—Docetaxel—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Vancomycin—Hypotension—Gemcitabine—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Insomnia—Irinotecan—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Vancomycin—Flushing—Docetaxel—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Vomiting—Tamoxifen—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Hypotension—Fluorouracil—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Hypersensitivity—Sunitinib—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Rash—Tamoxifen—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Dermatitis—Tamoxifen—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Vomiting—Erlotinib—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Dyspnoea—Irinotecan—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Headache—Tamoxifen—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Rash—Erlotinib—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Dermatitis—Erlotinib—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Insomnia—Gemcitabine—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Headache—Erlotinib—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Chills—Docetaxel—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Asthenia—Sunitinib—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Insomnia—Fluorouracil—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Hypokalaemia—Epirubicin—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Fatigue—Irinotecan—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Pruritus—Sunitinib—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Constipation—Irinotecan—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Pain—Irinotecan—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Dyspnoea—Fluorouracil—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Erythema—Docetaxel—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Malnutrition—Docetaxel—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Nausea—Tamoxifen—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Vancomycin—Fatigue—Gemcitabine—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Pain—Gemcitabine—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Constipation—Gemcitabine—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Nausea—Erlotinib—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Back pain—Docetaxel—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Pain—Fluorouracil—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Muscle spasms—Docetaxel—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Eosinophilia—Epirubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Dizziness—Sunitinib—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Abdominal pain—Irinotecan—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Body temperature increased—Irinotecan—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Anaemia—Docetaxel—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Vomiting—Sunitinib—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Vancomycin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Vancomycin—Neutropenia—Epirubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Rash—Sunitinib—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Dermatitis—Sunitinib—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Urticaria—Fluorouracil—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Headache—Sunitinib—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Palpitations—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Infestation—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Infestation NOS—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Nausea—Sunitinib—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Renal failure—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Asthenia—Irinotecan—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Urinary tract infection—Epirubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Asthenia—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Pruritus—Gemcitabine—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Infection—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Vancomycin—Agranulocytosis—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Vancomycin—Nervous system disorder—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Vancomycin—Pruritus—Fluorouracil—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Vancomycin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Tachycardia—Docetaxel—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Skin disorder—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Bradycardia—Epirubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Dizziness—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Oedema peripheral—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Hypotension—Docetaxel—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Vomiting—Irinotecan—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Dizziness—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Rash—Irinotecan—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Dermatitis—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Headache—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Insomnia—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Erythema multiforme—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Vomiting—Gemcitabine—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Dyspnoea—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Rash—Gemcitabine—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Dermatitis—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Tinnitus—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Headache—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Flushing—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Vomiting—Fluorouracil—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Rash—Fluorouracil—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Dermatitis—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Headache—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Fatigue—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Nausea—Irinotecan—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Pain—Docetaxel—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Constipation—Docetaxel—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Chills—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Nausea—Gemcitabine—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Erythema—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Malnutrition—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Nausea—Fluorouracil—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Flatulence—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Back pain—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Muscle spasms—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Abdominal pain—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Body temperature increased—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Chills—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Vancomycin—Anaemia—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—pancreatic cancer	0.000988	0.000988	CcSEcCtD
Vancomycin—Vertigo—Epirubicin—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—pancreatic cancer	0.00097	0.00097	CcSEcCtD
Vancomycin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000964	0.000964	CcSEcCtD
Vancomycin—Palpitations—Epirubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Vancomycin—Asthenia—Docetaxel—pancreatic cancer	0.000941	0.000941	CcSEcCtD
Vancomycin—Pruritus—Docetaxel—pancreatic cancer	0.000928	0.000928	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—pancreatic cancer	0.000927	0.000927	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Vancomycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000884	0.000884	CcSEcCtD
Vancomycin—Infection—Epirubicin—pancreatic cancer	0.000879	0.000879	CcSEcCtD
Vancomycin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Vancomycin—Dizziness—Docetaxel—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Vancomycin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000866	0.000866	CcSEcCtD
Vancomycin—Tachycardia—Epirubicin—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Vancomycin—Skin disorder—Epirubicin—pancreatic cancer	0.000859	0.000859	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Vancomycin—Vomiting—Docetaxel—pancreatic cancer	0.000834	0.000834	CcSEcCtD
Vancomycin—Rash—Docetaxel—pancreatic cancer	0.000827	0.000827	CcSEcCtD
Vancomycin—Hypotension—Epirubicin—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Vancomycin—Dermatitis—Docetaxel—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Vancomycin—Headache—Docetaxel—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000818	0.000818	CcSEcCtD
Vancomycin—Infection—Doxorubicin—pancreatic cancer	0.000813	0.000813	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000803	0.000803	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000801	0.000801	CcSEcCtD
Vancomycin—Insomnia—Epirubicin—pancreatic cancer	0.0008	0.0008	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—pancreatic cancer	0.000799	0.000799	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—pancreatic cancer	0.000795	0.000795	CcSEcCtD
Vancomycin—Dyspnoea—Epirubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Vancomycin—Nausea—Docetaxel—pancreatic cancer	0.000779	0.000779	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—pancreatic cancer	0.000765	0.000765	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000764	0.000764	CcSEcCtD
Vancomycin—Fatigue—Epirubicin—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Vancomycin—Constipation—Epirubicin—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Vancomycin—Pain—Epirubicin—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Vancomycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Vancomycin—Urticaria—Epirubicin—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Vancomycin—Pain—Doxorubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Vancomycin—Abdominal pain—Epirubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Vancomycin—Body temperature increased—Epirubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000669	0.000669	CcSEcCtD
Vancomycin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000652	0.000652	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Vancomycin—Asthenia—Epirubicin—pancreatic cancer	0.000635	0.000635	CcSEcCtD
Vancomycin—Pruritus—Epirubicin—pancreatic cancer	0.000626	0.000626	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000603	0.000603	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Vancomycin—Dizziness—Epirubicin—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—pancreatic cancer	0.000579	0.000579	CcSEcCtD
Vancomycin—Vomiting—Epirubicin—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Vancomycin—Rash—Epirubicin—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Vancomycin—Dermatitis—Epirubicin—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Vancomycin—Headache—Epirubicin—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Vancomycin—Nausea—Epirubicin—pancreatic cancer	0.000525	0.000525	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—pancreatic cancer	0.00052	0.00052	CcSEcCtD
Vancomycin—Rash—Doxorubicin—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Vancomycin—Headache—Doxorubicin—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—pancreatic cancer	0.000486	0.000486	CcSEcCtD
